Loading…

Anti-influenza Sesquiterpene from the Roots of Reynoutria japonica

One new flavonol glycoside, 4′-O-methylmyricitrin 3′-O-β-D-glucopyranoside (1), one new sesquiterpene, reynoudiol (11), as well as the 12 known compounds (2–10, 12–14) quercetin 3-O-methyl ether (2), quercitrin (3), isorhamnetin 3-α-L-rhamnopyranoside (4), tamarixetin 3-α-L-rhamnopyranoside (5), myr...

Full description

Saved in:
Bibliographic Details
Published in:Natural product communications 2014-03, Vol.9 (3), p.315-318
Main Authors: Nhiem, Nguyen Xuan, Van Kiem, Phan, Van Minh, Chau, Hoai, Nguyen Thi, Duc, Ho Viet, Tai, Bui Huu, Quang, Tran Hong, Le Tuan Anh, Hoang, Yeo, Sang-Gu, Song, Jae-Hyoung, Cheon, Doo-Sung, Park, Moon Ho, Ko, Hyun-Jeong, Kim, Seung Hyun
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:One new flavonol glycoside, 4′-O-methylmyricitrin 3′-O-β-D-glucopyranoside (1), one new sesquiterpene, reynoudiol (11), as well as the 12 known compounds (2–10, 12–14) quercetin 3-O-methyl ether (2), quercitrin (3), isorhamnetin 3-α-L-rhamnopyranoside (4), tamarixetin 3-α-L-rhamnopyranoside (5), myricitrin (6), 4′-O-methylmyricitrin (7), isorhamnetin 3-O-β-D-xylopyranosyl (1→2)-O-β-D-glucopyranoside (8), isorhamnetin 3-O-β-D-apiofuranosyl-(1→2)-O-β-D-glucopyranoside (9), (+)-catechin (10), 7-drimene-3,11,12-triol (12), clovane-2β,9α-diol (13), and α-cadinol (14), were isolated from the methanol extract of Reynoutria japonica roots. Based on in vitro screening of the anti-influenza activity of the isolated compounds, reynoudiol showed significantly higher activity than that of oseltamivir phosphate at the same concentration, and did not induce any detectable cytopathic effect in MDCK cells. The CC50 of reynoudiol was above 50 μM and could inhibit influenza virus infection with an IC50 of 0.29 ± 0.01 μM. The therapeutic index (TI) of reynoudiol against influenza infection was 172.4, and thus, this compound can be potentially used to treat oseltamivir-resistant influenza virus infection.
ISSN:1934-578X
1555-9475
DOI:10.1177/1934578X1400900308